Tyrosine phosphatases as regulators of skeletal development and metabolism

Journal of Cellular Biochemistry

Volumn 96, Issue 2, 2005, Pages 262-277

  Schiller, Katherine R ^a   Mauro, Laura J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cartilage; Dual specificity phosphatase; Limb bud; Osteoblast; Osteoclast; Skeleton; Tyrosine phosphatase

Indexed keywords

CARBONATE DEHYDRATASE; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SH2; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; PROTEOCHONDROITIN SULFATE;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE METASTASIS; CARTILAGE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; EMBRYO; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LIMB BUD; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETON;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; HUMANS; LIMB BUD; PHOSPHOTYROSINE; PROTEIN-TYROSINE-PHOSPHATASE; SIGNAL TRANSDUCTION;

EID: 26444523586     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20515     Document Type: Article

References (90)

1. Alonso A, Sasin J, Bottini N, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T. 2004. Protein tyrosine phosphatases in the human genome. Cell 117:699-711.
2. Amoui M, Baylink DJ, Tillman JB, Lau KH. 2003. Expression of a structurally unique osteoclastic protein-tyrosine phosphatase is driven by an alternative intronic, cell type-specific promoter. J Biol Chem 278:44273-44280.
3. Aoki K, Didomenico E, Sims NA, Mukhopadhyay K, Neff L, Houghton A, Amling M, Levy JB, Home WC, Baron R. 1999. The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: Increased resorption and osteopenia in me(v)/me(v) mutant mice. Bone 25:261-267.
4. Aubin J. 1998. Bone stem cells. J Cell Biochem 30-31:73-82.
5. Augustine KA, Rossi RM, Silbiger SM, Bucay N, Duryea D, Marshall WS, Medlock ES. 2000a. Evidence that the protein tyrosine phosphatase (PC12,Br7,Sl) gamma(-) isoform modulates chondrogenic patterning and growth. Int J Dev Biol 44:361-371.
6. Augustine KA, Silbiger SM, Bucay N, Ulias L, Boynton A, Trebasky LD, Medlock ES. 2000b. Protein tyrosine phosphatase (PC12, Br7,Sl) family: Expression characterization in the adult human and mouse. Anat Rec 258:221-234.
7. Beltran PJ, Bixby JL. 2003. Receptor protein tyrosine phosphatases as mediators of cellular adhesion. Front Biosci 8:D87-D99.
8. Bottini N, Bottini E, Gloria-Bottini F, Mustelin T. 2002. Low-molecular-weight protein tyrosine phosphatase and human disease: In search of biochemical mechanisms. Arch Immunol Ther Exp (Warsz) 50:95-104.
9. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423:337-342.
10. Canalis E, Bilezikian JP, Angeli A, Giustina A. 2004. Perspectives on glucocorticoid-induced osteoporosis. Bone 34:593-598.
11. Chandrasekharan UM, Yang L, Walters A, Howe P, DiCorleto PE. 2004. Role of CL-100, a dual specificity phosphatase, in thrombin-induced endothelial cell activation. J Biol Chem 279:46678-46685.
12. Charbonneau H, Tonks NK, Kumar S, Diltz CD, Harrylock M, Cool DE, Krebs EG, Fischer EH, Walsh KA. 1989. Human placenta protein-tyrosine-phosphatase: Amino acid sequence and relationship to a family of receptor-like proteins. Proc Natl Acad Sci USA 86:5252-5256.
13. Chellaiah MA, Biswas RS, Yuen D, Alvarez UM, Hruska KA. 2001. Phosphatidylinositol 3,4,5-trisphosphate directs association of Src homology 2-containing signaling proteins with gelsolin. J Biol Chem 276:47434-47444.
14. Chengalvala MV, Bapat AR, Hurlburt WW, Kostek B, Gonder DS, Mastroeni RA, Frail DE. 2001. Biochemical characterization of osteo-testicular protein tyrosine phosphatase and its functional significance in rat primary osteoblasts. Biochemistry 40:814-821.
15. Chernoff J, Schievella AR, Jost CA, Erikson RL, Neel BG. 1990. Cloning of a cDNA for a major human protein-tyrosine-phosphatase. Proc Natl Acad Sci USA 87:2735-2739.
16. Chiusaroli R, Knobler H, Luxenburg C, Sanjay A, Granot-Attas S, Tiran Z, Miyazaki T, Harmelin A, Baron R, Elson A. 2004. Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo. Mol Biol Cell 15:234-244.
17. Cousin W, Courseaux A, Ladoux A, Dani C, Peraldi P. 2004. Cloning of hOST-PTP: The only example of a protein-tyrosine-phosphatase the function of which has been lost between rodent and human. Biochem Biophys Res Commun 321:259-265.
18. Dacquin R, Mee PJ, Kawaguchi J, Olmsted-Davis EA, Gallagher JA, Nichols J, Lee K, Karsenty G, Smith A. 2004. Knock-in of nuclear localised beta-galactosidase reveals that the tyrosine phosphatase Ptprv is specifically expressed in cells of the bone collar. Dev Dyn 229:826-834.
19. Dorfman K, Carrasco D, Gruda M, Ryan C, Lira SA, Bravo R. 1996. Disruption of the erp/mkp-1 gene does not affect mouse development: Normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene 13:925-931.
20. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CG, et al. 1999. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544-1548.
21. Engelbrecht Y, de Wet H, Horsch K, Langeveldt CR, Hough FS, Hulley PA. 2003. Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. Endocrinology 144:412-422.
22. Farooq A, Zhou MM. 2004. Structure and regulation of MAPK phosphatases. Cell Signal 16:769-779.
23. Garton AJ, Tonks NK. 1994. PTP-PEST: A protein tyrosine phosphatase regulated by serine phosphorylation. EMBO J 13:3763-3771.
24. Garton AJ, Tonks NK. 1999. Regulation of fibroblast motility by the protein tyrosine phosphatase PTP-PEST. J Biol Chem 274:3811-3818.
25. Gotoh N, Ito M, Yamamoto S, Yoshino I, Song N, Wang Y, Lax I, Schlessinger J, Shibuya M, Lang RA. 2004. Tyrosine phosphorylation sites on FRS2alpha responsible for Shp2 recruitment are critical for induction of lens and retina. Proc Natl Acad Sci USA 101:17144-17149.
26. Guan KL, Haun RS, Watson SJ, Geahlen RL, Dixon JE. 1990. Cloning and expression of a protein-tyrosine-phosphatase. Proc Natl Acad Sci USA 87:1501-1505.
27. Gupta A, Lee BS, Khadeer MA, Tang Z, Chellaiah M, Abu-Amer Y, Goldknopf J, Hruska KA. 2003. Leupaxin is a critical adaptor protein in the adhesion zone of the osteoclast. J Bone Miner Res 18:669-685.
28. Hanafusa H, Torii S, Yasunaga T, Matsumoto K, Nishida E. 2004. Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty. J Biol Chem 279:22992-22995.
29. Homme M, Schmitt CP, Mehls O, Schaefer F. 2004. Mechanisms of mitogen-activated protein kinase inhibition by parathyroid hormone in osteoblast-like cells. J Am Soc Nephrol 15:2844-2850.
30. Hulley PA, Conradie MM, Langeveldt CR, Hough FS. 2002. Glucocorticoid-induced osteoporosis in the rat is prevented by the tyrosine phosphatase inhibitor, sodium orthovanadate. Bone 31:220-229.
31. Hunter T. 1998. The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: Its role in cell growth and disease. Philos Trans R Soc Lond B Biol Sci 353:583-605.
32. Hunter T. 2000. Signaling-2000 and beyond. Cell 100:113-127.
33. Imai S, Kaksonen M, Raulo E, Kinnunen T, Fages C, Meng X, Lakso M, Rauvala H. 1998. Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM). J Cell Biol 143:1113-1128.
34. Johnson KG, Van Vactor D. 2003. Receptor protein tyrosine phosphatases in nervous system development. Physiol Rev 83:1-24.
35. Karaplis AC. 2002. Embryonic development of bone and the molecular regulation of intramembraneous and endochondral bone formation. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. San Diego: Academic Press.
36. Kawakami Y, Rodriguez-Leon J, Koth CM, Buscher D, Itoh T, Raya A, Ng JK, Esteban CR, Takahashi S, Henrique D, Schwarz MF, Asahara H, Izpisua Belmonte JC. 2003. MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb. Nat Cell Biol 5:513-519.
37. Lathrop W, Jordan J, Eustice D, Chen D. 1999. Rat osteotesticular phosphatase gene (Esp): Genomic structure and chromosome location. Mamm Genome 10:366-370.
38. Lau KH, Baylink DJ. 2003. Osteoblastic tartrate-resistant acid phosphatase: Its potential role in the molecular mechanism of osteogenic action of fluoride. J Bone Miner Res 18:1897-1900.
39. Lau KH, Freeman TK, Baylink DJ. 1987. Purification and characterization of an acid phosphatase that displays phosphotyrosyl-protein phosphatase activity from bovine cortical bone matrix. J Biol Chem 262:1389-1397.
40. Lau KH, Tanimoto H, Baylink DJ. 1988. Vanadate stimulates bone cell proliferation and bone collagen synthesis in vitro. Endocrinology 123:2858-2867.
41. Lau KH, Farley JR, Baylink DJ. 1989a. Phosphotyrosyl protein phosphatases. Biochem J 257:23-36.
42. Lau KHW, Farley JR, Freeman TK, Baylink DJ. 1989b. A proposed mechanism of the mitogenic action of fluoride on bone cells: Inhibition of the activity of an osteoblastic acid phosphatase. Metabolism 38:858-868.
43. Lee K, Nichols J, Smith A. 1996. Identification of a developmentally regulated protein tyrosine phosphatase in embryonic stem cells that is a marker of pluripotential epiblast and early mesoderm. Mech Dev 59:153-164.
44. Li X, Oghi KA, Zhang J, Krones A, Bush KT, Glass CK, Nigam SK, Aggarwal AK, Maas R, Rose DW, Rosenfeld MG. 2003. Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature 426:247-254.
45. Mariani FV, Martin GR. 2003. Deciphering skeletal patterning: Clues from the limb. Nature 423:319-325.
46. Mauro LJ, Olmsted EA, Skrobacz BM, Mourey RJ, Davis AR, Dixon JE. 1994. Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation. J Biol Chem 269:30659-30667.
47. Mauro LJ, Olmsted EA, Davis AR, Dixon JE. 1996. Parathyroid hormone regulates the expression of the receptor protein tyrosine phosphatase, OST-PTP, in rat osteoblast-like cells. Endocrinology 137:925-933.
48. Meng K, Rodriguez-Pena A, Dimitrov T, Chen W, Yamin M, Noda M, Deuel TF. 2000. Pleiotrophin signals increased tyrosine phosphorylation of beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta [In Process Citation]. Proc Natl Acad Sci USA 97:2603-2608.
49. Miyazaki T, Sanjay A, Neff L, Tanaka S, Home WC, Baron R. 2004. Src kinase activity is essential for osteoclast function. J Biol Chem 279:17660-17666.
50. Morrison DF, Mauro LJ. 2000. Structural characterization and chromosomal localization of the mouse cDNA and gene encoding the bone tyrosine phosphatase, mOST-PTP. Gene 257:195-208.
51. Naski MC, Ornitz DM. 1998. FGF signaling in skeletal development. Front Biosci 3:D781-D794.
52. Neel BG, Gu H, Pao L. 2003. The 'Shping' news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28:284-293.
53. Nilsson I, Hoffmann I. 2000. Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res 4:107-114.
54. Olsen BR, Reginato AM, Wang W. 2000. Bone development. Annu Rev Cell Dev Biol 16:191-220.
55. Ostman A, Bohmer FD. 2001. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Trends Cell Biol 11:258-266.
56. Ostman A, Yang Q, Tonks NK. 1994. Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density. Proc Natl Acad Sci USA 91:9680-9684.
57. Puzas JE, Brand JS. 1985. Bone cell phosphotyrosine phosphatase: Characterization and regulation by calcitropic hormones. Endocrinology 116:2463-2468.
58. Qi M, Ikematsu S, Maeda N, Ichihara-Tanaka K, Sakuma S, Noda M, Muramatsu T, Kadomatsu K. 2001. Haptotactic migration induced by midkine. Involvement of protein-tyrosine phosphatase zeta, mitogen-activated protein kinase, and phosphatidylinositol 3-kinase. J Biol Chem 276:15868-15875.
59. Qin L, Qiu P, Wang L, Li X, Swarthout JT, Soteropoulos P, Tolias P, Partridge NC. 2003. Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics. J Biol Chem 278:19723-19731.
60. 1 to S phase. J Biol Chem 280:3104-3111.
61. Qu CK, Yu WM, Azzarelli B, Cooper S, Broxmeyer HE, Feng GS. 1998. Biased suppression of hematopoiesis and multiple developmental defects in chimeric mice containing Shp-2 mutant cells. Mol Cell Biol 18:6075-6082.
62. Rauvala H, Huttunen HJ, Fages C, Kaksonen M, Kinnunen T, Imai S, Raulo E, Kilpelainen I. 2000. Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility. Matrix Biol 19:377-387.
63. Sakaue H, Ogawa W, Nakamura T, Mori T, Nakamura K, Kasuga M. 2004. Role of MAPK phosphatase-1 (MKP-1) in adipocyte differentiation. J Biol Chem 279:39951-39957.
64. Saxton TM, Ciruna BG, Holmyard D, Kulkarni S, Harpal K, Rossant J, Pawson T. 2000. The SH2 tyrosine phosphatase shp2 is required for mammalian limb development. Nat Genet 24:420-423.
65. Shultz LD, Coman DR, Bailey CL, Beamer WG, Sidman CL. 1984. "Viable motheaten," a new allele at the motheaten locus. I. Pathology. Am J Pathol 116:179-192.
66. Shultz L, Schweitzer P, Rajan T, Yi T, Ihle J, Matthews R, Thomas M, Beier D. 1993. Mutations at the murine motheaten locus are within the hematopoietic cell protein tyrosine phosphatase (Hcph) gene. Cell 73:1445-1454.
67. Soriano P, Montgomery C, Geske R, Bradley A. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693-702.
68. Southey MC, Findlay DM, Kemp BE. 1995. Regulation of membrane-associated tyrosine phosphatases in UMR 106.06 osteoblast-like cells. Biochem J 305:485-490.
69. Suhr SM, Pamula S, Baylink DJ, Lau KH. 2001. Antisense oligodeoxynucleotide evidence that a unique osteoclastic protein-tyrosine phosphatase is essential for osteoclastic resorption. J Bone Miner Res 16:1795-1803.
70. Swarthout JT, D'Alonzo RC, Selvamurugan N, Partridge NC. 2002. Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 282:1-17.
71. Swarup G, Cohen S, Garbers DL. 1981. Selective dephosphorylation of proteins containing phosphotyrosine by alkaline phosphatases. J Biol Chem 256:8197-8201.
72. Swarup G, Cohen S, Garners DL. 1982. Inhibition of phosphotyrosyl-protein phosphatase activity by vanadate. Biochem Biophys Res Comm 107:1104-1109.
73. Tanaka S, Amling M, Neff L, Peyman A, Uhlmann E, Levy JB, Baron R. 1996. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Nature 383:528-531.
74. Tare RS, Oreffo RO, Clarke NM, Roach HI. 2002a. Pleiotrophin/osteoblast- stimulating factor 1: Dissecting its diverse functions in bone formation. J Bone Miner Res 17:2009-2020.
75. Tare RS, Oreffo RO, Sato K, Rauvala H, Clarke NM, Roach HI. 2002b. Effects of targeted overexpression of pleiotrophin on postnatal bone development. Biochem Biophys Res Commun 298:324-332.
76. Thomas PE, Wharram BL, Goyal M, Wiggins JE, Holzman LB, Wiggins RC. 1994. GLEPP1, a renal glomerular epithelial cell (podocyte) membrane protein-tyrosine phosphatase. Identification, molecular cloning, and characterization in rabbit. J Biol Chem 269:19953-19961.
77. Tootle TL, Silver SJ, Davies EL, Newman V, Latek RR, Mills IA, Selengut JD, Parlikar BE, Rebay I. 2003. The transcription factor Eyes absent is a protein tyrosine phosphatase. Nature 426:299-302.
78. Tosh D, Slack JM. 2002. How cells change their phenotype. Nat Rev Mol Cell Biol 3:187-194.
79. Umeda S, Beamer WG, Takagi K, Naito M, Hayashi S, Yonemitsu H, Yi T, Shultz LD. 1999. Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density. Am J Pathol 155:223-233.
80. Walton KM, Dixon JE. 1993. Protein tyrosine phosphatases. Ann Rev Biochem 62:101-120.
81. Wharram BL, Goyal M, Gillespie PJ, Wiggins JE, Kershaw DB, Holzman LB, Dysko RC, Saunders TL, Samuelson LC, Wiggins RC. 2000. Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate. J Clin Invest 106:1281-1290.
82. Wheeler MA, Townsend MK, Yunker LA, Mauro LJ. 2002. Transcriptional activation of the tyrosine phosphatase gene, OST-PTP, during osteoblast differentiation. J Cell Biochem 87:363-376.
83. William Lau KH, Farley JR, Baylink DJ. 1985. Phosphotyrosyl-specific protein phosphatase activity of a bovine skeletal acid phosphatase: Comparison with the phosphotyrosyl protein phosphatase activity of skeletal alkaline phosphatase. J Biol Chem 260:4653-4660.
84. William Lau KH, Freeman TK, Baylink DJ. 1987. Purification and characterization of an acid phosphatase that displays phosphotyrosyl-protein phosphatase activity from bovine cortical bone matrix. J Biol Chem 262:1389-1397.
85. Wong BR, Besser D, Kim N, Arron JR, Vologodskaia M, Hanafusa H, Choi Y. 1999. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell 4:1041-1049.
86. Wu LW, Baylink DJ, Lau KH. 1996. Molecular cloning and expression of a unique rabbit osteoclastic phosphotyrosyl phosphatase. Biochem J 316:515-523.
87. Yu K, Xu J, Liu Z, Sosic D, Shao J, Olson EN, Towler DA, Ornitz DM. 2003. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130:3063-3074.
88. Yunker LA, Carlson CS, Mauro LJ. 2002. Spatial and temporal expression of the tyrosine phosphatase, OST-PTP, during osteogenesis. J Bone Mineral Res 17:8246.
89. Yunker LA, Undersander A, Lian JB, Stein GS, Carlson CS, Mauro LJ. 2004. The tyrosine phosphatase, OST-PTP, is expressed in mesenchymal progenitor cells early during skeletogenesis in the mouse. J Cell Biochem 93:761-773.
90. Zhang Z, Jimi E, Bothwell AL. 2003. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis. J Immunol 171:3620-3626.